已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Corticosteroids Versus Teprotumumab for the Treatment of Thyroid Eye Disease. Does Either Mitigate the Need for Additional Treatments?

医学 队列 入射(几何) 回顾性队列研究 倾向得分匹配 心理干预 内科学 队列研究 格雷夫斯病 儿科 甲状腺 甲基强的松龙 不利影响 甲状腺疾病 外科 疾病 眼病 加药 甲状腺功能测试 药物治疗 Graves眼病 临床试验 优势比 前瞻性队列研究 风险因素 甲状腺功能
作者
Suyoung Choi,Sumit Shah,Patcharaporn Chandraparnik,Karen M. Wai,Ehsan Rahimy,Euna Koo,Chase A. Ludwig,Farzad Pakdel,Chrysoula Dosiou,Prithvi Mruthyunjaya,Andrea L. Kossler
出处
期刊:Thyroid [Mary Ann Liebert, Inc.]
卷期号:36 (1): 99-107
标识
DOI:10.1177/10507256251408731
摘要

Background:The treatment paradigm for thyroid eye disease (TED) in the United States has shifted from corticosteroids toward targeted therapies such as teprotumumab. However, it remains unknown whether teprotumumab decreases the need for subsequent treatments for TED compared with intravenous methylprednisolone (IVMP). This study compares the long-term need for additional medical or surgical interventions in TED patients treated with teprotumumab versus IVMP. Methods:A retrospective cohort study identified TED patients treated with IVMP or teprotumumab utilizing the TriNetX Analytics platform. Patients with comorbidities requiring high-dose steroids, prior TED therapy within 6 months, or concurrent TED treatments were excluded. Propensity score matching (PSM) adjusted for baseline demographic and TED-related risk factor differences. Patients were followed for 6, 12, and 18 months after a 6-month washout period. The primary outcome was the incidence of additional TED-related interventions. Secondary outcomes included post-treatment care trajectories, treatment burden, and complexity, assessed through longitudinal pathway analysis. Results:The IVMP cohort included 308 patients, and the teprotumumab cohort included 417; after PSM, each contained 263 patients. No significant differences were found in the incidence of additional TED-related interventions between cohorts. A similar percentage required additional medical therapies (41% vs. 37%, p = 0.423), while fewer in the IVMP cohort underwent additional surgical interventions (3.8% vs. 8.8%, p = 0.019, 4.8% vs. 10.0%, p = 0.040) at 12 and 18 months. Among those needing additional TED interventions, the IVMP cohort exhibited a higher treatment burden and more complex treatment trajectories, requiring a greater average number of treatments (2.34 vs. 1.34 per patient; 32.8% vs. 5.5% requiring ≥3 additional treatments). Conclusions:TED patients treated with IVMP or teprotumumab had similar overall rates of additional interventions. However, IVMP was associated with greater treatment complexity, requiring more varied medical therapies. Teprotumumab-treated patients typically required fewer additional medical therapies and underwent more surgical interventions as a second-line step, suggesting that teprotumumab may simplify the treatment pathway. These data have important implications for patient education and future assessment of the cost-effectiveness of TED therapies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
阿蛋完成签到,获得积分10
1秒前
lishuang发布了新的文献求助10
2秒前
4秒前
思源的应助被monster采纳,获得10
4秒前
4秒前
雪白十三完成签到,获得积分10
5秒前
在水一方的应助被人间理想采纳,获得10
7秒前
7秒前
脑洞疼的应助被长情的雨采纳,获得10
7秒前
7秒前
weather_clear完成签到 ,获得积分10
8秒前
8秒前
9秒前
布洛芬发布了新的文献求助10
10秒前
汉堡包的应助被耳东采纳,获得10
12秒前
邱c发布了新的文献求助10
12秒前
2026221709发布了新的文献求助30
12秒前
徐豆芽完成签到,获得积分20
12秒前
huanfeng完成签到,获得积分10
13秒前
CipherSage的应助被monster采纳,获得10
14秒前
Fascinate完成签到 ,获得积分10
15秒前
Rr发布了新的文献求助10
15秒前
16秒前
18秒前
18秒前
Luvv完成签到,获得积分10
20秒前
阳光发布了新的文献求助10
21秒前
22秒前
人间理想发布了新的文献求助10
22秒前
机智的兔子完成签到,获得积分10
23秒前
23秒前
耳东发布了新的文献求助10
24秒前
25秒前
无极微光的应助被Jonathan采纳,获得20
25秒前
啦啦啦发布了新的文献求助10
25秒前
Ava的应助被JiaYouguo采纳,获得10
25秒前
菜菜完成签到,获得积分10
28秒前
hoichai发布了新的文献求助10
28秒前
28秒前
喜悦寒凝发布了新的文献求助10
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184536
求助须知:如何正确求助?哪些是违规求助? 9573526
关于积分的说明 21832132
捐赠科研通 7781791
什么是DOI,文献DOI怎么找? 3434376
关于科研通互助平台的介绍 2558490
邀请新用户注册赠送积分活动 2480989